Video

Kanika Sehgal, MBBS: The Psychological Distress of C Difficile Patients

Author(s):

Treating the disease could reduce the risk of patient distress.

The psychological distress of patients can be a major challenge and hurdles for doctors, particularly those who are not psychiatrists.

But the main source of distress for many is the condition of the disease they are dealing with.

However, in data presented at 2022 Digestive Disease Week Annual Meeting in San Diego, investigators found on significant psychological distress in these patients at the time of symptom development for patients with Clostridioides difficile infection (CDI).

In an interview with HCPLive®, Kanika Sehgal, MBBS, Research Fellow at Mayo Clinic Rochester, explained how the study shed light on how distress manifests in patients.

In the study, the investigators examined adult patients with an index episode of CDI, no history of irritable bowel syndrome or inflammatory bowel disease and all 8 patients developed abdominal pain that was present for at least 1 day per week and was related to change in bowel movement consistency and frequency.

While the results may be surprising, Sehgal said one of the things doctors can do to treat distress is to treat the underlying disease. By treating C difficile infections successfully using first-line therapeutics, Sehgal said there will be a drastic reduction in the risk of psychological distress.

Related Videos
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Sibgha Zaheer, MD: Determining Washout Period With Fitusiran, Emicizumab Transition for Hemophilia
Pavan K. (Tem) Bendapudi, MD: Large-Scale Analyses Elucidate Genetic Risk of Thrombosis
Seema Rani, MD: Examining Sleep Health in Youth With SCD
Daniel Wang: A More Appropriate Ferritin Threshold is Cost-Effective for Iron Deficiency Screening
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
© 2025 MJH Life Sciences

All rights reserved.